Product NDC: | 68788-8999 |
Proprietary Name: | Lansoprazole |
Non Proprietary Name: | Lansoprazole |
Active Ingredient(s): | 15 mg/1 & nbsp; Lansoprazole |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68788-8999 |
Labeler Name: | Preferred Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202176 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130604 |
Package NDC: | 68788-8999-1 |
Package Description: | 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-8999-1) |
NDC Code | 68788-8999-1 |
Proprietary Name | Lansoprazole |
Package Description | 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68788-8999-1) |
Product NDC | 68788-8999 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lansoprazole |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130604 |
Marketing Category Name | ANDA |
Labeler Name | Preferred Pharmaceuticals, Inc. |
Substance Name | LANSOPRAZOLE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |